SCHEMBL7619215

SCHEMBL7619215

CCCCCCCC(=O)N(C(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)CN)[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ NMUR2 Q9GZQ4 4/20 0.58
▸ NMUR1 Q9HB89 4/20 0.58
▸ APLNR P35414 2/20 0.55
▸ TFPI P10646 2/20 0.54
▸ NPY2R P49146 4/20 0.53
▸ NPY4R P50391 4/20 0.53
▸ NPY5R Q15761 4/20 0.53
▸ NPY1R P25929 3/20 0.53
▸ OPRM1 P35372 6/20 0.53
▸ OPRK1 P41145 6/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16150700 0.90 APLNR (0.64) APLNR
SCHEMBL7053513 0.89 NMUR2 (0.47) NMUR2NMUR1APLNROPRM1
SCHEMBL30166497 0.88 APLNR (0.62) APLNRTFPINPY2RNPY4RNPY5R
SCHEMBL5059932 0.88 APLNR (0.64) APLNR
SCHEMBL5068412 0.87 APLNR (0.60) APLNRTFPI
SCHEMBL4459179 0.87 APLNR (0.63) APLNR
SCHEMBL31455187 0.83 NMUR2 (0.65) NMUR2NMUR1TFPINPY2RNPY4R
SCHEMBL29526046 0.83 APLNR (0.64) APLNRTFPINPY2RNPY4RNPY5R
SCHEMBL29525577 0.83 APLNR (0.64) APLNRTFPINPY2RNPY4RNPY5R
SCHEMBL4464636 0.83 APLNR (0.54) APLNR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020187938-A1 Ghrelin antagonists ARDANA BIOSCIENCE LIMITED (GB) 2002-12-12 — — US claimed
US-20020187938-A1 Ghrelin antagonists ARDANA BIOSCIENCE LIMITED (GB) 2002-12-12 — — US disclosed
Send feedback